Lucence Life Sciences Pte.

HealthcareSeries ASingapore, Singapore

See the investors Find investors for my raise

Latest round: Series A
Last raised: May 2023
Total raised: $75M
Investors: 9

About Lucence Life Sciences Pte.

Based in Singapore, Lucence Life Sciences Pte. Ltd is a company that develops technology for early cancer detection. The company uses a deep genome intelligence created by different professionals from fields such as oncology, laboratory medicine, technology development, and data science. In May 2023, Lucence Life Sciences Pte., Parkway Holdings and SGInnovate. Lucence Life Sciences Pte. Ltd is a precision oncology company that develops advanced genomic tests for cancer detection and treatment. The company specializes in liquid biopsies non-invasive tests that analyze blood samples to detect genetic changes linked to cancer. Its flagship product, LiquidHALLMARK, uses proprietary AmpliMark technology to identify cancer biomarkers with high sensitivity, supporting personalized treatment decisions.

Who invested in Lucence Life Sciences Pte.

9 investors across 3 rounds

See all investors in Lucence Life Sciences Pte.

Funding rounds

Series A
May 17, 2023
Amount
$46M
Investors
Locked
Series A
Nov 10, 2019
Amount
$20M
Investors
Locked
Series A
Sep 18, 2017
Amount
$9.2M
Investors
Locked

Questions about Lucence Life Sciences Pte.

Who invested in Lucence Life Sciences Pte.?

Lucence Life Sciences Pte. has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lucence Life Sciences Pte. raised?

Lucence Life Sciences Pte. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Lucence Life Sciences Pte. last raise money?

Lucence Life Sciences Pte.'s most recent round on record is a Series A, in May 2023.

What does Lucence Life Sciences Pte. do?

Based in Singapore, Lucence Life Sciences Pte.

Where is Lucence Life Sciences Pte. headquartered?

Lucence Life Sciences Pte. is headquartered in Singapore, Singapore.

Which VCs invest in companies like Lucence Life Sciences Pte.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Lucence Life Sciences Pte.'s stage. Their profiles are linked below.

VCs backing healthcare startups at Series A

Shanghai State-owned Capital Investment Leading FundChina · Cheque $31M–$100M$8.4B dry powder Yufu CapitalChina · Cheque $761.4K–$6.6M$4.7B dry powder Taibao CapitalChina · Cheque $29.9M–$100M$3.2B dry powder Hengxu CapitalChina · Cheque $159.1K–$3.9M$1.5B dry powder Riverhead CapitalChina · Cheque $1.5M–$13.5M$1.4B dry powder Shanghai Growth InvestmentChina · Cheque $1.2M–$10.8M$1.4B dry powder

Raising like Lucence Life Sciences Pte.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.